终末期肾病患者心血管疾病的危险因素(2)
2. Mahmoodi BK， Matsushita K， Woodward M. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension： a meta-analysis. [J].Lancet 2012; 380： 1649–1661
3.Moradi H， Sica DA， Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. [J]. Am J Nephrol 2013; 38： 136–148
4. Haugen E， Nath KA. The involvement of oxidative stress in the progression of renal injury. [J]. Blood Purif 1999; 17： 58–65
5. Sun J， Axelsson J， Machowska A. et al. Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. [J].Clin J Am Soc Nephrol 2016; 11： 1163–1172
6. 劉英杰，郭维康，刘文虎.慢性肾脏病继发性甲状旁腺功能亢进与心血管钙化的联系[J].临床和实验医学杂志，2018，17(09)：1008-1009.
7. Vashistha T， Kalantar-Zadeh K， Molnar MZ. et al. Dialysis modality and correction of uremic metabolic acidosis： relationship with all-cause and cause-specific mortality. [J].Clin J Am Soc Nephrol 2013; 8： 254–264
通信作者：廖湘平, http://www.100md.com(李艳荣 廖湘平)
3.Moradi H， Sica DA， Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. [J]. Am J Nephrol 2013; 38： 136–148
4. Haugen E， Nath KA. The involvement of oxidative stress in the progression of renal injury. [J]. Blood Purif 1999; 17： 58–65
5. Sun J， Axelsson J， Machowska A. et al. Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. [J].Clin J Am Soc Nephrol 2016; 11： 1163–1172
6. 劉英杰，郭维康，刘文虎.慢性肾脏病继发性甲状旁腺功能亢进与心血管钙化的联系[J].临床和实验医学杂志，2018，17(09)：1008-1009.
7. Vashistha T， Kalantar-Zadeh K， Molnar MZ. et al. Dialysis modality and correction of uremic metabolic acidosis： relationship with all-cause and cause-specific mortality. [J].Clin J Am Soc Nephrol 2013; 8： 254–264
通信作者：廖湘平, http://www.100md.com(李艳荣 廖湘平)